SNRPD1 and SNRPE, among other Sm proteins, were shown overexpressed in a subset of highly aggressive breast cancers, and were proposed as novel onco-therapeutic targets since the depletion of either one halted breast cancer growth without affecting the quasi-normal MCF10A cells [16]. The gene discussed is SNRPE; the disease is breast carcinoma.